Indication
Fluid retention associated with menses
Fluid retention associated with menses is a cyclical clinical state characterized by temporary extracellular water and sodium accumulation occurring during the late luteal phase and early onset of menstruation. Read more about Fluid retention associated with menses
2 drugs 2 manufacturers
Drugs that treat it
Common Fluid retention associated with menses therapies.
DIUREX MAX (pamabrom)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonFluid retention associated with menses is a cyclical clinical state characterized by temporary extracellular water and sodium accumulation occurring during the late luteal phase and early onset of menstruation.
Affecting ovulatory and menstruating females across their reproductive lifespan, it primarily impacts systemic fluid regulation, the vascular endothelium, and peripheral interstitial tissues.
It is pathophysiologically driven by shifting ovarian sex hormone levels, primarily fluctuations in estrogen and progesterone that influence the renin-angiotensin-aldosterone axis and capillary permeability.
Clinically, it manifests as transient abdominal bloating, peripheral edema of the extremities, breast engorgement or tenderness, and modest, self-limiting weight gain that typically resolves following the establishment of menstrual flow.
- nih.gov
Fluid retention associated with menses is a cyclical clinical state characterized by temporary extracellular water and sodium accumulation occurring during the late luteal phase and early onset of menstruation Affecting ovulatory and menstruating females across their reproductive lifespan, it primarily impacts systemic fluid regulation, the vascular endothelium, and peripheral interstitial tissues
- attiliodalberto.com
Fluid retention associated with menses is a cyclical clinical state characterized by temporary extracellular water and sodium accumulation occurring during the late luteal phase and early onset of menstruation Affecting ovulatory and menstruating females across their reproductive lifespan, it primarily impacts systemic fluid regulation, the vascular endothelium, and peripheral interstitial tissues It is pathophysiologically driven by shifting ovarian sex hormone levels, primarily fluctuations in...
- clarityhealthclinic.ca
Affecting ovulatory and menstruating females across their reproductive lifespan, it primarily impacts systemic fluid regulation, the vascular endothelium, and peripheral interstitial tissues
- mayoclinic.org
It is pathophysiologically driven by shifting ovarian sex hormone levels, primarily fluctuations in estrogen and progesterone that influence the renin-angiotensin-aldosterone axis and capillary permeability
- nih.gov
Clinically, it manifests as transient abdominal bloating, peripheral edema of the extremities, breast engorgement or tenderness, and modest, self-limiting weight gain that typically resolves following the establishment of menstrual flow
- wikipedia.org
Clinically, it manifests as transient abdominal bloating, peripheral edema of the extremities, breast engorgement or tenderness, and modest, self-limiting weight gain that typically resolves following the establishment of menstrual flow
- hormonic.de
Clinically, it manifests as transient abdominal bloating, peripheral edema of the extremities, breast engorgement or tenderness, and modest, self-limiting weight gain that typically resolves following the establishment of menstrual flow
Personalize your experience
Follow Fluid retention associated with menses and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.